相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease
Bo Yi Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain
Rezaul Md Karim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Synthesis and Structural Characterization of β-Turn Mimics Containing (Z)-Chloroalkene Dipeptide Isosteres
Yuki Kodama et al.
JOURNAL OF ORGANIC CHEMISTRY (2022)
Modulating Conformational Preferences by Allylic Strain toward Improved Physical Properties and Binding Interactions
Hongtao Zhao
ACS OMEGA (2022)
Surprising lipophilicity observations identify unexpected conformational effects
Matthew W. D. Perry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Conformational Switch of Benzanilide Derivative Induced by Acid; Effect of Pentafluorobenzoyl Group
Ryu Yamasaki et al.
JOURNAL OF ORGANIC CHEMISTRY (2022)
Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Cav1.1 by Dihydropyridine Compounds**
Shuai Gao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Large-Scale Analysis of Bioactive Ligand Conformational Strain Energy by Ab Initio Calculation
Jiahui Tong et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis
Franck Brebion et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
Matthew W. D. Perry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The Good, the Bad, and the Twisted Revisited: An Analysis of Ligand Geometry in Highly Resolved Protein-Ligand X-ray Structures
John W. Liebeschuetz
JOURNAL OF MEDICINAL CHEMISTRY (2021)
PI3K inhibitors are finally coming of age
Bart Vanhaesebroeck et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Human PLD structures enable drug design and characterization of isoenzyme selectivity
Claire M. Metrick et al.
NATURE CHEMICAL BIOLOGY (2020)
Conformational Design Principles in Total Synthesis
Renzhi Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme
Urvashi Sharma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase
Denise Rageot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Why Do N-Alkylated Anilides Bend Over? The Factors Dictating the Divergent Conformational Preferences of 2° and 3° N-Aryl Amides
Gabrielle J. Pros et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors
Doris A. Schuetz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design
Gyles E. Cozier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Crystal structure of (S)-5-chloro-N-({2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide
Jie Shen et al.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2018)
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 24(6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs
Alessio Lodola et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane
Akira Mizuno et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Conformational control in structure-based drug design
Yajun Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization
Akira Mizuno et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs
Jadd Shelton et al.
CHEMICAL REVIEWS (2016)
Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51
Steffen Gaali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates
Peter J. Thornton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Cyclopropyl Fragment is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules
Tanaji T. Talele
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist
Yajun Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of novel pyrazole-containing benzamides as potent ROR gamma inverse agonists
Tao Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of biaryl carboxylamides as potent RORγ inverse agonists
Jianhua Chao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Fluorine in Drug Design: A Case Study with Fluoroanisoles
Li Xing et al.
CHEMMEDCHEM (2015)
Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2
Kurt G. Pike et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors
Paul A. Barsanti et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
Zengjun Fang et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis
Jakob Felding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic Profiles
David J. St Jean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis
Sven Weiler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Allosteric Competitive Inhibitors of the Glucose-1-phosphate Thymidylyltransferase (RmlA) from Pseudomonas aeruginosa
Magnus S. Alphey et al.
ACS CHEMICAL BIOLOGY (2013)
Profound Methyl Effects in Drug Discovery and a Call for New C-H Methylation Reactions
Heike Schoenherr et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Development of Dual PLD1/2 and PLD2 Selective Inhibitors from a Common 1,3,8-Triazaspiro[4.5]decane Core: Discovery of ML298 and ML299 That Decrease Invasive Migration in U87-MG Glioblastoma Cells
Matthew C. O'Reilly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Torsion Angle Preferences in Druglike Chemical Space: A Comprehensive Guide
Christin Schaerfer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Lars Petter Jordheim et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis
Jean Quancard et al.
CHEMISTRY & BIOLOGY (2012)
Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
Paul J. Coleman et al.
CHEMMEDCHEM (2012)
Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
Lars Baerfacker et al.
CHEMMEDCHEM (2012)
Ideal Molecular Conformation versus Crystal Site Symmetry
Robert A. Pascal et al.
CRYSTAL GROWTH & DESIGN (2012)
Systematic conformational bias in small-molecule crystal structures is rare and explicable
Aurora J. Cruz-Cabeza et al.
CRYSTENGCOMM (2012)
Chemoenzymatic Synthesis of Stegobinone and Stegobiol, Components of the Natural Sex Pheromone of the Drugstore Beetle (Stegobium paniceum L.)
Dimitris Kalaitzakis et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2012)
Methyl Effects on Protein-Ligand Binding
Cheryl S. Leung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation
James S. Scott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Beyond Size, Ionization State, and Lipophilicity: Influence of Molecular Topology on Absorption, Distribution, Metabolism, Excretion, and Toxicity for Druglike Compounds
Yidong Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery and synthesis of a new class of opioid ligand having a 3-azabicyclo[3.1.0]hexane core. An example of a 'magic methyl' giving a 35-fold improvement in binding
Graham Lunn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
An Evaluation of Peptide-Bond Isosteres
Amit Choudhary et al.
CHEMBIOCHEM (2011)
Phospholipase D: Enzymology, Functionality, and Chemical Modulation
Paige E. Selvy et al.
CHEMICAL REVIEWS (2011)
Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry
Minoru Ishikawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
J. Jean Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5
Victor J. Cee et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives
Nicholas A. McGrath et al.
JOURNAL OF CHEMICAL EDUCATION (2010)
A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu
Stefan Grimme et al.
JOURNAL OF CHEMICAL PHYSICS (2010)
Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray Structure and Biological Evaluation
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Medicinal Chemist's Guide to Molecular Interactions
Caterina Bissantz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Phospholipase D2 Ablation Ameliorates Alzheimer's Disease-Linked Synaptic Dysfunction and Cognitive Deficits
Tiago Gil Oliveira et al.
JOURNAL OF NEUROSCIENCE (2010)
Retroviral intasome assembly and inhibition of DNA strand transfer
Stephen Hare et al.
NATURE (2010)
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
Alex Berndt et al.
NATURE CHEMICAL BIOLOGY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells
David A. Foster
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Quinolone Carboxylic Acids as a Novel Monoketo Acid Class of Human Immunodeficiency Virus Type 1 Integrase Inhibitors
Motohide Sato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of (S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (Apremilast), a Potent and Orally Active Phosphodiesterase 4 and Tumor Necrosis Factor-α Inhibitor
Hon-Wah Man et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Development of the Renal Glucose Reabsorption Inhibitors: A New Mechanism for the Pharmacotherapy of Diabetes Mellitus Type 2
William N. Washburn
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
Sarah A. Scott et al.
NATURE CHEMICAL BIOLOGY (2009)
Synthesis and conformational analysis of α,α-difluoroalkyl heteroaryl ethers
Daniel B. Horne et al.
TETRAHEDRON LETTERS (2009)
Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis
Ken A. Brameld et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
(+)-discodermolide: total synthesis, construction of novel analogues, and biological evaluation
Amos B. Smith et al.
TETRAHEDRON (2008)
Finding a way out: lymphocyte egress from lymphoid organs
Susan R. Schwab et al.
NATURE IMMUNOLOGY (2007)
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cyclopropyl conjugation and ketyl anions: When do things begin to fall apart?
J. M. Tanko et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine.: Application to the design of novel bradykinin B1 receptor antagonists
MR Wood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939):: An oral, direct factor Xa inhibitor
S Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance
D Tu et al.
CELL (2005)
Convergent approach to (E)-alkene and cyclopropane peptide isosteres
P Wipf et al.
ORGANIC LETTERS (2005)
The discovery of tadalafil:: A novel and highly selective PDE5 inhibitor.: 2:: 2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione analogues
A Daugan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Conformation of secondary amides.: A predictive algorithm that correlates DFT-calculated structures and experimental proton chemical shifts
M Avalos et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
On the structure and torsional potential of trifluoromethoxybenzene: an ab initio and density functional study
J Klocker et al.
CHEMICAL PHYSICS LETTERS (2003)
New software for searching the Cambridge Structural Database and visualizing crystal structures
IJ Bruno et al.
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2002)
Structure-based design of novel potent nonpeptide thrombin inhibitors
NH Hauel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Can we predict the conformational preference of amides?
M Avalos et al.
JOURNAL OF ORGANIC CHEMISTRY (2001)
Molecular mechanics calculations on carbonyl compounds. II. Open-chain ketones
CH Langley et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2001)
Hyperconjugation not steric repulsion leads to the staggered structure of ethane
V Pophristic et al.
NATURE (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Participation of the beta-hydroxyketone part for potent cytotoxicity of callystatin A, a spongean polyketide
N Murakami et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
分享论文
